Showing 39,981 - 40,000 results of 101,506 for search '(( 5 ((((mean decrease) OR (teer decrease))) OR (a decrease)) ) OR ( 5 point decrease ))', query time: 1.65s Refine Results
  1. 39981

    Dephosphorylation of AMPK substrate i.e. acetyl CoA carboxylase (ACC) initiates neuritogenic effect of SIM. by Varshiesh Raina (457377)

    Published 2013
    “…SIM led to a significant (<i>p</i> < 0.05<sup>*</sup>) increase in pACC (Ser-79) levels at 2 hrs which was followed by a gradual decrease. …”
  2. 39982

    Schematic of Unstable Multiple-Peak Solution in a Mass Conserved Reaction–Diffusion System by Mikiya Otsuji (75660)

    Published 2013
    “…The u-form molecules convert v-form molecules into u-form, and this positive feedback is so strong under the condition where ∂<i>P<sub>e</sub></i>/∂<i> N̄</i> < 0 [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.0030108#pcbi-0030108-b048" target="_blank">48</a>] that infusion of molecules into the space causes a decrease in v-form molecules. …”
  3. 39983

    Pulmonary function tests – an easy selection method for respiratory-gated radiotherapy in patients with left-sided breast cancer by Mari H. B. Hjelstuen (3642640)

    Published 2017
    “…</b> Dose to the heart (V25Gy and D<sub>mean</sub>) decreased with increasing TLV-CT. …”
  4. 39984
  5. 39985
  6. 39986
  7. 39987

    Data_Sheet_1_Hurricane Risk Assessment of Petroleum Infrastructure in a Changing Climate.pdf by Majid Ebad Sichani (9130160)

    Published 2020
    “…The results reveal that either an increase in mean sea level or a decrease in storm forward speed increases the maximum water elevations in the HSC for storms that produce maximum wind setup in Galveston Bay (FEMA 33 and FEMA 36), resulting in larger economic loss estimates. …”
  8. 39988

    Table_1_Safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of WBP216, a novel IL-6 monoclonal antibody, in patients with rheumatoid arthritis: A phase Ia random... by Xiaomei Leng (614420)

    Published 2023
    “…</p>Methods<p>In this double-blind, placebo-controlled, SAD, phase Ia study, patients with RA were randomized in a 3:1 (Group A1, 10 mg) and 6:2 (Group A2, 30 mg; Group A3, 75 mg; Group A4, 150 mg; Group A5, 300 mg) ratios to receive either ascending doses of WBP216 or placebo subcutaneously. …”
  9. 39989

    EHV-1 induces platelet activation in equine platelet-rich plasma in a concentration-dependent manner. by Tracy Stokol (718195)

    Published 2020
    “…RacL11 induced slightly stronger microvesiculation than Ab4, with a decrease in P-selectin expression at the higher PFU/cell of 1 and 5. * p < 0.001 for P-selectin and p = 0.002 for PDMP versus RK, 0.01 and 0.1 PFU/cell for each virus strain (except Ab4 at 0.5 PFU/cell was not significantly different from RK). ** p < 0.001 versus Ab4.…”
  10. 39990

    The optimal asset allocation between the S&P500 index and a risk-free asset as a function of the risk-free interest rate <i>r</i><sub><i>f</i></sub>. by Haim Levy (252011)

    Published 2021
    “…The bold line shows the optimal allocation to the stock index for a PT investor with the parameters in [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0248904#pone.0248904.ref023" target="_blank">23</a>]: <i>α</i> = <i>β</i> = 0.88, <i>λ</i> = 2.25 given by <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0248904#pone.0248904.e007" target="_blank">Eq 5</a>. …”
  11. 39991

    KDM1 revealed typical electrophysiological features of the K<sub>in</sub>-a subclade. by Anda L. Iosip (9749747)

    Published 2020
    “…The measured I<sub>SS</sub> were normalized to −150 mV and 100 mM K<sup>+</sup> at pH 4 (<i>n</i> = 4; mean ± SD). …”
  12. 39992
  13. 39993
  14. 39994

    Pulmonary function tests of mutant mice with reduced bioavailable VEGF indicate a restrictive lung disease. by Minna M. Wieck (849372)

    Published 2016
    “…Data are expressed as mean ± SEM. (B, C) Mutant mice also demonstrated a 30% decrease in hysteresis and compliance. …”
  15. 39995

    Heart graft rejection in Lew.1a recipients is significantly influenced by the presence of NK cells. by Oliver Beetz (6786137)

    Published 2019
    “…Of note, NK cell depletion caused a decrease of NKR-P1A<sup>+</sup> (NK cells and NKT cells) cells below the baseline of syngeneic controls whereas the NKR-P1A/B<sup>+</sup> (NK cells, NKT cells and Monocytes) cells were unaffected by the depletion (grey arrows), indicating abundant infiltration of NKR-P1B<sup>+</sup> monocytes. …”
  16. 39996

    Inequalities in Alcohol-Related Mortality in 17 European Countries: A Retrospective Analysis of Mortality Registers by Johan P. Mackenbach (147412)

    Published 2015
    “…<div><p>Background</p><p>Socioeconomic inequalities in alcohol-related mortality have been documented in several European countries, but it is unknown whether the magnitude of these inequalities differs between countries and whether these inequalities increase or decrease over time.</p><p>Methods and Findings</p><p>We collected and harmonized data on mortality from four alcohol-related causes (alcoholic psychosis, dependence, and abuse; alcoholic cardiomyopathy; alcoholic liver cirrhosis; and accidental poisoning by alcohol) by age, sex, education level, and occupational class in 20 European populations from 17 different countries, both for a recent period and for previous points in time, using data from mortality registers. …”
  17. 39997

    The interaction between tonic GABA<sub>A</sub>R signaling and glutamatergic activity. by Michelle Day (11617621)

    Published 2024
    “…Increasing depolarization (2–3 mV to 10<sup>−5</sup> S/cm<sup>2</sup> density) was accompanied by a dendritic spike in response to a glutamatergic input that was subthreshold in the absence of tonic GABA activation. …”
  18. 39998

    Personalized Prediction of Lifetime Benefits with Statin Therapy for Asymptomatic Individuals: A Modeling Study by Bart S. Ferket (107294)

    Published 2012
    “…In 2,428 participants (mean age 67.7 y, 35.5% men), statin therapy increased total life expectancy by 0.3 y (SD 0.2) and CVD-free life expectancy by 0.7 y (SD 0.4). …”
  19. 39999
  20. 40000